Status:
UNKNOWN
Photobiomodulation in Oral Lichen Planus
Lead Sponsor:
University of Nove de Julho
Conditions:
Lichen Planus, Oral
Low-Level Light Therapy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study was to compare the efficacy of PBM (660nm) and corticosteroid therapy with clobetasol propionate 0.05% in the treatment of OLP. This is a protocol for a randomized, controlled, d...
Detailed Description
Oral lichen planus is an idiopathic chronic mucocutaneous disease with a ride range of clinical manifestations, including white reticular patches, erosive/ulcerative and atrophic lesions, both associa...
Eligibility Criteria
Inclusion
- The participants in this study will be male and female (aged over 18 years) diagnosed with symptomatic oral lichen planus, based on the clinical and histopathological criteria of the World Health Organization (WHO).
Exclusion
- Patients with ongoing cancer; pregnant or breastfeeding women; patients with history of corticosteroids and nonsteroidal anti-inflammatory treatment in the last one months, patients with uncontrolled systemic disease; consumption of illicit drugs; use of medication associated with oral lichenoid reactions; amalgam restoration near to OLP lesions; epithelial dysplasia in the histopathological examination.
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT03320460
Start Date
November 1 2018
End Date
December 1 2020
Last Update
December 26 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Scholl of Dentistry, University of São Paulo
São Paulo, São Paulo, Brazil, 05508000